Referrals
  
Department of Surgery
info@columbiasurgery.org Referrals Patient Clinician Researcher
 Lung Transplant
Lung Diseases and Disorders
Treatment and Care
Patient Guide to Lung Transplantation
Four Steps to Successful Transplantation
Who is Eligible for Lung Transplantation
Pre-Transplant Evaluation
Waiting for Transplantation
When an Organ Becomes Available
Lung Transplant Surgery
Post-Transplant Recovery
Life After Transplantation
Follow-Up Care
Exercise Program
Staying in Touch with Your Transplant Team
Immunosuppression and Organ Rejection
Bronchoscopy/Lung Biopsy
Infections
Post-Transplant Medications
Nutritional Management After Transplantation
Health Care for Life
Support Services
Organ Donation
Research
Links
What’s New
Staff
Contact & Referrals

Lung Transplant
Lung Transplantation Patient Guide Immunosuppressant Medications After Lung Transplantation


Daclizumab and Basiliximab After Lung Transplantation

Zenapax® (daclizumab) and Simulect® (basilecmab)
Purpose Both are immunosuppressive medicines that help prevent organ rejection.
Dosage One of these medications, which are administered only by IV, may be given at the time of your operation, and in the first few days to weeks post-operatively.
When The transplant team orders the medication and it will be administered by the nurse during your hospitalization, or as an out patient in the Comprehensive Transplant Program.
Common Side Effects Constipation, nausea, diarrhea, edema, abdominal distention.

 Back to Medications List




















top
     Contact Us About Us  Ways to Give Site Map Disclaimer Find a Physician Patient Forms Intranet
Columbia University Medical Center NewYork-Presbyterian Hospital